Related Experiment Video
Updated: May 16, 2026

Rectal Organoid Morphology Analysis (ROMA): A Diagnostic Assay in Cystic Fibrosis
Published on: June 10, 2022
Jejunoileal atresia and cystic fibrosis: don't miss it
Carolien L Siersma1, Bart L Rottier, Jan Bf Hulscher
1Department of Pediatrics, Beatrix Children's Hospital, CA51 Hanzeplein 1, PO Box 30001, 9700 RB, Groningen, The Netherlands.
Insights
Cystic fibrosis (CF) is often missed in newborns with jejunal and ileal atresia (JIA). Early CFTR mutation testing in JIA infants improves outcomes and should be standard practice.
Area of Science:
- Medical Genetics
- Pediatric Surgery
- Neonatology
Background:
- Cystic fibrosis (CF) prevalence is higher in infants with jejunal and ileal atresia (JIA).
- Current practice often overlooks CFTR mutation testing in newborns with JIA.
- Leading textbooks do not list JIA as a presenting feature of CF.
Purpose of the Study:
- To investigate the diagnostic practices for cystic fibrosis in infants with jejunal and ileal atresia.
- To evaluate the association between CF testing and clinical outcomes in JIA patients.
- To advocate for improved diagnostic algorithms for CF in neonates with JIA.
Main Methods:
- Retrospective review of 50 patients with JIA over 18 years (1991-2008).
- Comparison of patients tested for CF (n=18) versus those not tested (n=32).
- Logistic regression and nonparametric tests used for statistical analysis (p<0.05).
Main Results:
- Only 36% of JIA infants were tested for CF.
- Patients tested for CF showed significantly higher rates of postoperative bilious retention and complications.
- CF was confirmed in 8% of the evaluated JIA cases.
Conclusions:
- CF testing is not consistently performed in newborns with JIA.
- Timely CF diagnosis and presymptomatic treatment significantly improve patient morbidity and mortality.
- Recommend sweat testing for term infants and CFTR DNA testing for preterm infants with JIA.
Background:
While an increased prevalence of cystic fibrosis (CF) in patients with jejunal atresia and ileal atresia (JIA) has been described previously, it still may not be a practice routine to indicate a sweat test or DNA test for CFTR mutations in newborns presenting with JIA. Leading textbooks do not mention JIA as a possible presenting clinical feature of CF. We describe two cases of JIA with a delayed diagnosis of CF (4 months [post mortem] and 19 months). This led to a retrospective review of all patients with JIA in our hospital. We hypothesised that also in the past although indicated further testing for CF had not always been performed.
Methods:
Over an 18-year period from January 1991 until December 2008, all cases of JIA in our centre were reviewed (n=50). We compared patients who have been tested for CF (n=18) with patients who have not been tested for CF (n=32), with respect to their patient characteristics, either by logistic regression analysis or a nonparametric test (p<0.05).
Results:
Of all 50 patients the proportion of infants actually tested for CF was 18 (36%). A statistical significant difference between the group of patients who were tested for CF versus the group of those who were not tested was found in a higher occurrence of postoperative bilious retention after 7 days (56% versus 25%, respectively), and postoperative complications (78% versus 34%, respectively). CF was confirmed in 4 (8%).
Conclusion:
Testing for CF in newborns presenting with JIA does not appear to be common practice. A timely diagnosis of CF leads to presymptomatic treatment and has beneficial effects on morbidity and mortality. CF should be tested for in all children with JIA. We recommend a sweat test for term children and CFTR DNA testing as a first step for preterm infants. Medical professional awareness may be increased if future editions of leading text books in the relevant fields should include JIA as an indication to follow an appropriate CF-diagnostic algorithm.
Trial Registration:
Statement on reporting of a clinical trial: This article is not based on a clinical trial.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Urologic Endoscopic Procedure: Cystoscopic Examination
Intestinal Obstruction I: Introduction
Diverticular Disease of the Colon
Intestinal Obstruction II: Pathophysiology

